Clinical Trials Logo

Filter by:
NCT ID: NCT05181020 Completed - Enteral Feeding Clinical Trials

Studying the Influence of Exposure to Maternal Voice on Oral Feeding Volumes in Preterm Infants

Start date: March 5, 2020
Phase: N/A
Study type: Interventional

Oral feeding is one of the primary functions of the neonatal brain. In preterm infant population, competency at oral feeding is one of the major milestones in preparation for discharge. Mother's voices have been shown to have a net stimulatory effect and premature infants have been found to have increased cardiorespiratory stability after listening to mother's voices. Main objective of this study is to determine if it is possible to expose preterm infant in a systematic manner to mother's voices before their feeds and to determine if this exposure results in an increase in their oral intake.

NCT ID: NCT05180747 Completed - Parkinson Disease Clinical Trials

BUrst vs. Spaced Physical Therapy for Parkinson's Disease: The BUS PT Timing Trial

Start date: August 3, 2020
Phase: N/A
Study type: Interventional

Many patients with Parkinson's Disease (PD) will encounter difficulties with balance, posture, and gait for which physical therapy (PT) has been shown to be beneficial. The purpose of this study is to randomize patients between standard "burst" PT versus "spaced" PT to inform on the optimal frequency of PT for PD patients. Burst PT in this study was defined as 2 PT visits per week for 6 weeks (12 sessions) and spaced PT, as 1 PT visit every other week for 6 months (12 sessions).

NCT ID: NCT05180630 Completed - Clinical trials for Hearing Loss, Sensorineural

Sound Quality Comparisons With Different Hearing Aid Couplings and Venting Systems

Start date: October 1, 2021
Phase: N/A
Study type: Interventional

Participants will be comparing the sound quality of their own voice and the sound quality of streamed music using universal couplings and a custom earmold with a dynamic vent.

NCT ID: NCT05180539 Completed - College Drinking Clinical Trials

A Multi-Component Alcohol and Sex Risk Intervention for College Students

SPLASH
Start date: September 23, 2021
Phase: N/A
Study type: Interventional

Hazardous alcohol use, sexually transmitted infections, and sexual violence are interrelated and highly prevalent public health concerns in college student populations. The current study seeks to develop a tri-pronged sex-positive intervention that addresses risky alcohol use, unsafe sex, and sexual violence for college men and women (ages 18-24). The study involves a small randomized pilot trial to demonstrate the feasibility and acceptability of the recruitment methods and research design. Preliminary evidence of intervention efficacy will also be evaluated.

NCT ID: NCT05180500 Completed - COVID-19 Clinical Trials

Safety and Acceptability of Q GRFT Nasal Spray for COVID-19 Prophylaxis

Start date: March 15, 2022
Phase: Phase 1
Study type: Interventional

This is a phase I randomized, placebo-controlled, single site to assess the local and systemic safety of intranasal Q-Griffithsin (Q-GRFT) after 14 doses in approximately 45 adult participants. Participants will be randomized 2:1 (Q-GRFT nasal spray: placebo nasal spray) resulting in 30 participants enrolled into the Q-GRFT arm and 15 participants enrolled into the placebo arm. A clinician will apply two metered doses of Q-GRFT in each nostril (400μl total) of the participant on the day of enrollment. Participants will be monitored in the clinic for 1 hour after administration and return for a 24-hour post dose visit. If safe and acceptable, a second period of daily administration by the participant for 13 days will commence. Safety assessments will be performed at day 7, day 14, and day 28 visits after the initiation of the second period. The expected duration of study participation for each participant will be approximately 6-8 weeks. The primary endpoint is the proportion of participants who experience a related Grade 2 or higher adverse event. Secondary and exploratory endpoints include persistence and systemic absorption of Q-GRFT, acceptability and the impact of Q-GRFT nasal spray on smell.

NCT ID: NCT05180357 Completed - Nasal Polyps Clinical Trials

RANS. Study in Patients With Severe Eosinophilic Asthma and Nasal Polyps.

RANS
Start date: November 23, 2021
Phase:
Study type: Observational

The purpose of this observational study is to describe the population of patients with SEA + NP who have been prescribed FASENRA and assess available clinical outcomes for both NP and asthma.

NCT ID: NCT05180279 Completed - Ulcerative Colitis Clinical Trials

The Impact of Circadian Misalignment on Colonic Barrier Homeostasis in Ulcerative Colitis

Start date: April 1, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate if circadian malalignment (unusual sleeping patterns), such as night shifts (sleeping during the day and being awake during the night time), worsens the inflammation of the gut. We hope to look at patients with Ulcerative Colitis and Healthy Controls.

NCT ID: NCT05179941 Completed - Shoulder Pain Clinical Trials

Subscapularis Indocyanine Green Perfusion Pilot Study

ICG
Start date: February 11, 2022
Phase: N/A
Study type: Interventional

The Purpose of this pilot study is to evaluate the feasibility of open wide-field imaging of indocyanine green ingress and egress during total shoulder arthroplasty. This study also hopes to characterize the relationship between tissue perfusion measured with DCE-FI and different approaches and techniques used in total shoulder arthroplasty. The long term goal of this study is to determine if there is a potential relationship between perfusion and patient reported outcomes and subscapularis failure.

NCT ID: NCT05179785 Completed - Bipolar Disorder Clinical Trials

Examining the Effect of EEG-guided Theta Burst Stimulation in Bipolar Disorder

Start date: March 23, 2022
Phase: N/A
Study type: Interventional

Bipolar Disorder (BD) is a common and highly debilitating psychiatric disorder, however, the predisposing brain mechanisms are poorly understood. Here, the investigators will conduct a proof of concept study that will examine the effect of electroencephalography (EEG)-guided theta burst stimulation (TBS) on reducing mania/hypomania-related affect and reward driven behavior in adults with BD. The investigators hypothesize that TBS will reduce mania/hypomania-related affect and reward driven behavior in adults with BD.

NCT ID: NCT05179525 Completed - Schizophrenia Clinical Trials

Comparative Bioavailability of Risperidone.

Start date: March 9, 2021
Phase: Phase 1
Study type: Interventional

This is an Open-Label, One-Sequence Study to Evaluate the Steady- State Comparative Bioavailability of Intramuscular Risperidone ISM® and EU Risperdal® (Sourced From Germany).